Who
Christopher James Stevens
Chief Operating Officer
Company insider
Files Form 4 as: Chief Operating Officer, Rocket Pharmaceuticals.
In numbers
- Trades disclosed
- 12
- Buys
- 0
- Sells
- 1
- Bought
- $0
- Sold
- $257K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 4 Aug 2025
- Last trade
- 11 Aug 2026
- Last filed
- 13 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Aug 2026filed 13 Aug 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $128K36,658 at $3.50 | filing |
| 11 Aug 2026filed 13 Aug 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $128K36,658 at $3.50 | filing |
| 3 Aug 2026filed 5 Aug 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —73,313 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —101,428 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —101,428 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —73,313 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —61,963 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —93,037 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —93,037 at $0.00 | filing |
| 11 Feb 2026filed 13 Feb 2026 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —61,963 at $0.00 | filing |
| 4 Aug 2025filed 6 Aug 2025 | RCKT Rocket Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —554,071 at $0.00 | filing |
| 4 Aug 2025filed 6 Aug 2025 | RCKT Rocket PharmaceuticalsBiotechnology | SEC FORM 4 Code A | —407,166 at $0.00 | filing |
News
Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Crosses Below Fifty Day Moving Average – Should You Sell?RCKT · dailypolitical.com · 22 Oct 2026
0 headlines in the last 90 days name Christopher James Stevens; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.